๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Fuzhou
Clinical trial register · China

Clinical Trials in Fuzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Fuzhou 35 Quanzhou 3 Zhangzhou 1 Guangzhou 1 Nanning 1
Narrow the registerReset
Recruitment status
Phase
Site location
Fuzhou35 Quanzhou3 Zhangzhou1 Guangzhou1 Nanning1
All 15 locations
Target enrolment
to

Trials with a site in Fuzhou

35 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
NCT07470840Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital
Phase 2
27
Fuzhou
2027-02-01
Not yet open
A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer
NCT07613567Locally Advanced Cervical Carcinoma
Fujian Cancer Hospital
Phase 3
486
Fuzhou
2026-09-01
Not yet open
A Prospective Study on the Clinical Value of Skin Test for Oxaliplatin Hypersensitivity Reaction and Its Correlation With Biomarkers
NCT07613905Hypersensitivity Reaction
Fujian Cancer Hospital
Not applicable
380
Fuzhou
2026-09-01
Not yet open
Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
NCT07469306Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2
130
Fuzhou, Longyan, Quanzhou
2026-08-10
Not yet open
Kumorixilib Plus Capecitabine and Letrozole for Neoadjuvant Treatment of HR-Positive HER2-Negative Breast Cancer
NCT07691333HR+/HER2- Breast Cancer, Breast Neoplasms
Fujian Cancer Hospital
Phase 2
35
Fuzhou, Quanzhou
2026-06-30
Recruiting
Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer
NCT07702708HR+/HER2- Breast Cancer, Breast Neoplasms
Fujian Cancer Hospital
Observational
100
Fuzhou, Quanzhou, Ningde, Sanming
2026-06-01
By invitation
Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC
NCT07738367Non-small Cell Lung Cancer(NSCLC)
Fujian Cancer Hospital
Phase 2
20
Fuzhou
2026-04-09
Recruiting
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
NCT07256236Cervical Cancer
Fujian Cancer Hospital
Phase 2
89
Fuzhou, Zhangzhou, Guangzhou, Nanning, Hohhot, Dalian, Jinan, Jining
2026-01-28
Recruiting
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
NCT07581834Breast Diseases, Breast Neoplasms, Dalpiciclib, Endocrine Breast Diseases
Fujian Cancer Hospital
Phase 2
2,000
Fuzhou, Chengdu
2026-01-21
Recruiting
Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)
NCT07320105Non-Small Cell Lung Cancer
Fujian Cancer Hospital
Phase 4
60
Fuzhou
2026-01-15
Not yet open
Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma
NCT07268690Nasopharyngeal Carcinoma by AJCC V9 Stage
Fujian Cancer Hospital
Phase 3
474
Fuzhou
2026-01-01
Recruiting
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
NCT06787183Locally Advanced Rectal Cancer With Liver Metastases
Fujian Cancer Hospital
Phase 2
42
Fuzhou
2025-12-01
Recruiting
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
NCT07055399Locally Advanced Cervical Cancer
Fujian Cancer Hospital
Phase 2
43
Fuzhou
2025-08-21
Not yet open
Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
NCT07070713Metastatic Colorectal Cancer With Left-sided Primary Tumor, Immunotherapy
Fujian Cancer Hospital
Phase 2
44
Fuzhou
2025-07-30
Not yet open
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
NCT06788171Colorectal Cancer Liver Metastasis
Fujian Cancer Hospital
Phase 2
35
Fuzhou
2025-03-01
Recruiting
CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma
NCT06095154Nasopharyngeal Carcinoma by AJCC V8 Stage
Fujian Cancer Hospital
Phase 3
474
Fuzhou
2025-01-01
Not yet open
Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
NCT06600841Platinum-resistant Ovarian Cancer (PROC), Immunotherapy
Fujian Cancer Hospital
Phase 2
37
Fuzhou
2024-10-01
Recruiting
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
NCT06140589Cervical Cancer
Fujian Cancer Hospital
Observational
200
Fuzhou
2024-09-07
Active, closed
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
NCT07104877Colorectal Cancer, Gastric Cancer (GC), Gastrointestinal Tumors
Fujian Cancer Hospital
Not applicable
25
Fuzhou
2024-04-18
Recruiting
A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
NCT06463834Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital
Phase 2
30
Fuzhou
2024-03-20
Not yet open
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
NCT06095167Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 3
476
Fuzhou
2024-01-01
Not yet open
MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
NCT06197126Cervical Cancer, Radiotherapy, Prognostic Model, MRI
Fujian Cancer Hospital
Observational
200
Fuzhou
2024-01-01
Not yet open
MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer
NCT06126393Endometrial Neoplasms
Fujian Cancer Hospital
Observational
350
Fuzhou
2024-01-01
Not yet open
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
NCT06101966Cervical Cancer, Radiotherapy, Distant Metastasis, Prognostic Model
Fujian Cancer Hospital
Observational
500
Fuzhou
2023-12-01
Not yet open
A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer
NCT06039982Cervix Carcinoma
Fujian Cancer Hospital
Observational
100
Fuzhou
2023-11-01
Recruiting
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.
NCT05624099Esophageal Neoplasms, Esophageal Diseases, Digestive System Neoplasms
Fujian Cancer Hospital
Phase 2
75
Fuzhou
2023-08-01
Recruiting
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
NCT05319639Gastric Cancer Stage IV
Fujian Cancer Hospital
Phase 1/2
51
Fuzhou
2023-02-16
Recruiting
Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
NCT05019690Advanced Triple Negative Breast Cancer
Fujian Cancer Hospital
Phase 1/2
29
Fuzhou
2021-10-01
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/fuzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Fuzhou that also match the filters currently applied.

How many clinical trials are recruiting in Fuzhou?

16 of the 35 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 17 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Fuzhou), 35 studies
PhaseStudiesRecruitingShare
Phase 216645.7%
Observational6217.1%
Phase 36317.1%
Not applicable318.6%
Phase 1/2225.7%
Phase 2/3112.9%
Phase 4112.9%

Most active sponsors

Lead sponsors with the most studies (Fuzhou)
Lead sponsorStudiesRecruiting
Fujian Cancer Hospital3516
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.